[biosecure] - Roche-Takeda NeoGuard™ Blue ad for market entry in western Indian megacities cluster
While what remains of hyper-capitalist India with its approximately 70 million inhabitants is dominated by Sun Pharmaceuticals and its yellow NeoGuard™ product line, the competition does not sleep.
The other main producer, Roche-Takeda (headquartered in Trieste, former Italy), tries again and again to gain a foothold among the bioinsecure Indian population.
Witness the aftermath of the synthetic nano-parasites (SNP/NanoSinp) and BioSev/VaccineGenocide dual crisis from the pharmaceutical mega-corporation competitor perspective.